JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M606412200 on August 1, 2006

J. Biol. Chem., Vol. 281, Issue 41, 30383-30392, October 13, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/41/30383    most recent
M606412200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laplante, P.
Right arrow Articles by Hébert, M.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laplante, P.
Right arrow Articles by Hébert, M.-J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Perlecan Proteolysis Induces an {alpha}2beta1 Integrin- and Src Family Kinase-dependent Anti-apoptotic Pathway in Fibroblasts in the Absence of Focal Adhesion Kinase Activation*

Patrick Laplante{ddagger}, Marc-André Raymond{ddagger}, Andrée Labelle{ddagger}, Jun-Ichi Abe§, Renato V. Iozzo, and Marie-Josée Hébert{ddagger}1

From the {ddagger}Centre de Recherche du Centre Hospitalier de l'Université de Montreal, University of Montreal, 1560 Sherbrooke East, Montreal, Quebec H2L 4M1, Canada, §Center for Cardiovascular Research, University of Rochester, Rochester, New York 14642, and Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Dysregulation of apoptosis in endothelial cells (EC) and fibroblasts contributes to fibrosis. We have shown previously that apoptosis of EC triggers the proteolysis of extracellular matrix components and the release of a C-terminal fragment of perlecan, which in turn inhibits apoptosis of fibroblasts. Here we have defined the receptors and pathways implicated in this anti-apoptotic response in fibroblasts. Neutralizing {alpha}2beta1 integrin activity in fibroblasts exposed to either medium conditioned by apoptotic EC (SSC) or a recombinant perlecan C-terminal fragment (LG3) prevented resistance to apoptosis and is associated with decreased levels of Akt phosphorylation. Co-incubation of fibroblasts for 24 h with SSC or LG3 in the presence of PP2 (AG1879), a biochemical inhibitor of Src family kinases (SFKs) and focal adhesion kinase, showed a significantly decreased anti-apoptotic response. However, focal adhesion kinase gene silencing with RNA interference did not inhibit the anti-apoptotic response in fibroblasts. Src phosphorylation was increased in fibroblasts exposed to SSC, and transfection of fibroblasts with constitutively active Src mutants induced an anti-apoptotic response that was not further increased by SSC. Also, Src–/–Fyn–/– fibroblasts failed to mount an anti-apoptotic response in presence of SSC for 24 h but developed a complete anti-apoptotic response when exposed to SSC for 7 days. These results suggest that extracellular matrix fragments produced by apoptotic EC initiate a state of resistance to apoptosis in fibroblasts via an {alpha}2beta1 integrin/SFK (Src and Fyn)/phosphatidylinositol 3-kinase (PI3K)-dependent pathway. In the long term, additional SFK members are recruited for sustaining the anti-apoptotic response, which could play crucial roles in abnormal fibrogenic healing.


Received for publication, July 5, 2006

* This work was supported by an operating grant (MT-15447) from the Canadian Institutes of Health Research and the Kidney Foundation of Canada (to M.-J. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Scholar of the Fonds de la Recherche en Santé du Québec. To whom correspondence and reprint requests should be addressed: CRCHUM, 1560 Sherbrooke E., Montreal, Quebec H2L 4M1, Canada. Tel.: 514-890-8000 (ext. 25393); Fax: 514-412–7661; E-mail: marie-josee.hebert.chum{at}ssss.gouv.qc.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-F. Cailhier, I. Sirois, P. Laplante, S. Lepage, M.-A. Raymond, N. Brassard, A. Prat, R. V. Iozzo, A. V. Pshezhetsky, and M.-J. Hebert
Caspase-3 Activation Triggers Extracellular Cathepsin L Release and Endorepellin Proteolysis
J. Biol. Chem., October 3, 2008; 283(40): 27220 - 27229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
O. Bock, J. Hoftmann, K. Theophile, K. Hussein, B. Wiese, J. Schlue, and H. Kreipe
Bone Morphogenetic Proteins Are Overexpressed in the Bone Marrow of Primary Myelofibrosis and Are Apparently Induced by Fibrogenic Cytokines
Am. J. Pathol., April 1, 2008; 172(4): 951 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. P. Woodall, A. Nystrom, R. A. Iozzo, J. A. Eble, S. Niland, T. Krieg, B. Eckes, A. Pozzi, and R. V. Iozzo
Integrin {alpha}2 1 Is the Required Receptor for Endorepellin Angiostatic Activity
J. Biol. Chem., January 25, 2008; 283(4): 2335 - 2343.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. C Farach-Carson and D. D Carson
Perlecan a multifunctional extracellular proteoglycan scaffold
Glycobiology, September 1, 2007; 17(9): 897 - 905.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H.-R. Kang, C. G. Lee, R. J. Homer, and J. A. Elias
Semaphorin 7A plays a critical role in TGF-{beta}1-induced pulmonary fibrosis
J. Exp. Med., May 14, 2007; 204(5): 1083 - 1093.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Bix, R. A. Iozzo, B. Woodall, M. Burrows, A. McQuillan, S. Campbell, G. B. Fields, and R. V. Iozzo
Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the {alpha}2{beta}1-integrin receptor
Blood, May 1, 2007; 109(9): 3745 - 3748.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.